|
市場調査レポート
商品コード
1746892
インフルエンザ診断薬の日本市場：製品別、検査タイプ別、インフルエンザタイプ別、エンドユーザー別、地域別、2025年～2033年Japan Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| インフルエンザ診断薬の日本市場：製品別、検査タイプ別、インフルエンザタイプ別、エンドユーザー別、地域別、2025年～2033年 |
|
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 115 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本のインフルエンザ診断薬の市場規模は2024年に6,320万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1億500万米ドルに達し、2025年から2033年にかけて5.3%の成長率（CAGR）を示すと予測しています。市場は、ワクチン接種キャンペーンの拡大、ポイントオブケア検査による利便性、インフルエンザウイルスに関する研究の強化、公衆衛生イニシアチブを通じた認知度の向上など、いくつかの要因によって牽引されています。
本レポートで扱う主な質問
- 日本のインフルエンザ診断薬市場はこれまでどのように推移し、今後どのように推移するのか？
- 日本のインフルエンザ診断薬市場にCOVID-19が与えた影響は？
- 日本のインフルエンザ診断薬市場の製品別区分は？
- 日本のインフルエンザ診断薬市場の検査タイプ別区分は？
- 日本のインフルエンザ診断薬市場のインフルエンザタイプ別内訳は？
- 日本のインフルエンザ診断薬市場のエンドユーザー別区分は？
- 日本のインフルエンザ診断薬市場のバリューチェーンにおける様々なステージとは？
- 日本のインフルエンザ診断薬の主要な促進要因と課題は何か？
- 日本のインフルエンザ診断薬市場の構造と主要企業は？
- 日本のインフルエンザ診断薬市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本のインフルエンザ診断薬市場-イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本のインフルエンザ診断薬市場情勢
- 過去および現在の市場動向（2019年～2024年）
- 市場予測（2025年～2033年）
第6章 日本のインフルエンザ診断薬市場-製品別内訳
- 検査キット・試薬
- 機器
- その他
第7章 日本のインフルエンザ診断薬市場-検査タイプ別内訳
- 分子診断検査
- 従来の診断検査
第8章 日本のインフルエンザ診断薬市場-インフルエンザタイプ別内訳
- A型インフルエンザ
- B型インフルエンザ
- C型インフルエンザ
第9章 日本のインフルエンザ診断薬市場-エンドユーザー別内訳
- 病院
- 診断検査室
- その他
第10章 日本のインフルエンザ診断薬市場-競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第11章 主要企業のプロファイル
第12章 日本のインフルエンザ診断薬市場-業界分析
- 促進要因、抑制要因、機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第13章 付録
Japan influenza diagnostics market size reached USD 63.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 105.0 Million by 2033, exhibiting a growth rate (CAGR) of 5.3% during 2025-2033. The market is being driven by several factors, including the expansion of vaccination campaigns, the convenience offered by point-of-care testing, intensified research into influenza viruses, and increased awareness through public health initiatives.
Influenza, commonly referred to as the flu, is a viral infection that primarily targets the respiratory system, affecting areas such as the nose, throat, and lungs. The realm of influenza diagnostics encompasses a variety of immunoassay tests designed to detect the presence of nucleoprotein antigens from influenza A and B viruses in respiratory samples. Among the available diagnostic methods are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serological tests, and rapid molecular assays. These diagnostic options are relied upon by healthcare professionals to promptly identify and categorize influenza strains, facilitating effective treatment decisions and enabling efficient public health management.
Japan Influenza Diagnostics Market Trends:
The influenza diagnostics market in Japan is witnessing substantial growth, driven by a combination of factors. Foremost among these is the increasing incidence of flu outbreaks, which necessitates effective diagnostic solutions. Apart from this, the growing concerns regarding the potential for pandemics have spurred investments in diagnostic capabilities, making a significant contribution to market expansion. Furthermore, continuous technological advancements in the field are enhancing the accuracy and speed of diagnostic tests, positively impacting the market's growth trajectory. Besides this, public awareness campaigns focused on the importance of timely testing have encouraged more individuals to seek diagnostic services, further catalyzing market demand. Japan's rising healthcare spending supports the adoption of advanced diagnostic methods, contributing to market growth. Additionally, elderly individuals, who are more vulnerable to severe cases of the flu, are driving increased demand for diagnostic services. The growth of urban populations in Japan has led to higher infection rates, underscoring the need for robust diagnostic solutions. Frequent travel within the country and internationally has accelerated the spread of the flu, further highlighting the importance of efficient diagnostics. These factors will collectively create numerous opportunities for the influenza diagnostics market in Japan over the forecasted period.
Japan Influenza Diagnostics Market Segmentation:
Product Insights:
- Test Kit and Reagents
- Instruments
- Others
Test Type Insights:
- Molecular Diagnostic Tests
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Tests
- Others
- Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Direct Fluorescent Antibody Test
- Serological Tests
Type of Flu Insights:
- Type A Flu
- Type B Flu
- Type C Flu
End User Insights:
- Hospitals
- Diagnostic Laboratories
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan influenza diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan influenza diagnostics market?
- What is the breakup of the Japan influenza diagnostics market on the basis of product?
- What is the breakup of the Japan influenza diagnostics market on the basis of test type?
- What is the breakup of the Japan influenza diagnostics market on the basis of type of flu?
- What is the breakup of the Japan influenza diagnostics market on the basis of end user?
- What are the various stages in the value chain of the Japan influenza diagnostics market?
- What are the key driving factors and challenges in the Japan influenza diagnostics?
- What is the structure of the Japan influenza diagnostics market and who are the key players?
- What is the degree of competition in the Japan influenza diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Influenza Diagnostics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Influenza Diagnostics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Influenza Diagnostics Market - Breakup by Product
- 6.1 Test Kit and Reagents
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Others
- 6.3.1 Historical and Current Market Trends (2019-2024)
- 6.3.2 Market Forecast (2025-2033)
7 Japan Influenza Diagnostics Market - Breakup by Test Type
- 7.1 Molecular Diagnostic Tests
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
- 7.1.3.1 Polymerase Chain Reaction
- 7.1.3.2 Isothermal Nucleic Acid Amplification Tests
- 7.1.3.3 Others
- 7.1.4 Market Forecast (2025-2033)
- 7.2 Traditional Diagnostic Tests
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
- 7.2.3.1 Rapid Influenza Diagnostic Tests
- 7.2.3.2 Viral Culture Tests
- 7.2.3.3 Direct Fluorescent Antibody Test
- 7.2.3.4 Serological Tests
- 7.2.4 Market Forecast (2025-2033)
8 Japan Influenza Diagnostics Market - Breakup by Type of Flu
- 8.1 Type A Flu
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Type B Flu
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Type C Flu
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
9 Japan Influenza Diagnostics Market - Breakup by End User
- 9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)
10 Japan Influenza Diagnostics Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Influenza Diagnostics Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
13 Appendix
